A detailed history of Meritage Portfolio Management transactions in In Mode Ltd. stock. As of the latest transaction made, Meritage Portfolio Management holds 14,765 shares of INMD stock, worth $263,259. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,765
Previous 13,481 9.52%
Holding current value
$263,259
Previous $246,000 1.63%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$15.43 - $19.06 $19,812 - $24,473
1,284 Added 9.52%
14,765 $250,000
Q2 2024

Aug 08, 2024

SELL
$17.02 - $21.0 $170 - $210
-10 Reduced 0.07%
13,481 $246,000
Q1 2024

Apr 29, 2024

SELL
$20.45 - $26.49 $439,347 - $569,111
-21,484 Reduced 61.43%
13,491 $292,000
Q4 2023

Feb 02, 2024

BUY
$19.02 - $30.13 $308,789 - $489,160
16,235 Added 86.63%
34,975 $778,000
Q3 2023

Oct 30, 2023

BUY
$30.46 - $46.04 $6,092 - $9,208
200 Added 1.08%
18,740 $571,000
Q2 2023

Jul 31, 2023

BUY
$31.57 - $37.73 $134,772 - $161,069
4,269 Added 29.91%
18,540 $692,000
Q1 2023

Apr 25, 2023

BUY
$29.72 - $41.45 $237,968 - $331,890
8,007 Added 127.83%
14,271 $456,000
Q4 2022

Feb 01, 2023

SELL
$30.23 - $38.71 $76,723 - $98,245
-2,538 Reduced 28.83%
6,264 $224,000
Q3 2022

Oct 25, 2022

BUY
$22.51 - $38.27 $198,133 - $336,852
8,802 New
8,802 $256,000
Q2 2022

Jul 25, 2022

SELL
$20.97 - $37.47 $183,047 - $327,075
-8,729 Closed
0 $0
Q1 2022

Apr 25, 2022

SELL
$34.38 - $65.77 $5.17 Million - $9.89 Million
-150,441 Reduced 94.52%
8,729 $322,000
Q4 2021

Jan 28, 2022

BUY
$63.78 - $97.86 $5.04 Million - $7.74 Million
79,070 Added 98.71%
159,170 $11.2 Million
Q3 2021

Oct 26, 2021

BUY
$45.58 - $88.24 $3.65 Million - $7.07 Million
80,100 New
80,100 $12.8 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.48B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.